Screening for Cervical Cancer This article reviews recent evidence from the International
Agency for Research on Cancer on the best methods of screening for cervical cancer …

Importance Cervical cancer can be prevented with detection and treatment of precancerous
cell changes caused primarily by high-risk types of human papillomavirus (hrHPV), the …

Importance The number of deaths from cervical cancer in the United States has decreased
substantially since the implementation of widespread cervical cancer screening and has …

Background In four randomised trials, human papillomavirus (HPV)-based screening for
cervical cancer was compared with cytology-based cervical screening, and precursors of …

Background Cervical cancer screening has traditionally been based on cervical cytology.
Given the aetiological relationship between human papillomavirus (HPV) infection and …

Cervical cancer is the second most common cancer in women worldwide, and knowledge
regarding its cause and pathogenesis is expanding rapidly. Persistent infection with one of …

Background Human papillomavirus (HPV) testing is known to be more sensitive, but less
specific than cytology for detecting cervical intraepithelial neoplasia (CIN). We assessed the …

In a project coordinated by the International Agency for Research on Cancer (IARC) 31
experts from 11 European countries and IARC have developed supplements to the current …

Background To determine whether testing for DNA of oncogenic human papillomaviruses
(HPV) is superior to the Papanicolaou (Pap) test for cervical-cancer screening, we …

Given the strong etiologic link between high‐risk HPV infection and cervical cancer high‐risk
HPV testing is now being considered as an alternative for cytology‐based cervical cancer …